O-1602 - CAS 317321-41-8

O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-independent manner, in Hep55B cells with elevated intracellular calcium.

Calcium Channel, Cannabinoid Receptor

GPCR/G Protein, Metabolism, Membrane transporter/Ion channel

317272

0.9985

C17H22O2

258.36

CC1=C(C(O)=CC(O)=C1)[C@H]2[C@H](C(C)=C)CCC(C)=C2

-20°C

Ice Packs

Small Compound